40 results
Thumbnail

D2.17 - Prostate-Specific Protein Can f 5 as an Allergen in Seminal Fluid Hypersensitivity: A Case Study

Thumbnail

D2.18 - Identification of Potential Allergens in Lobularia maritima: A Case Study

Thumbnail

D2.20 - Chronic Idiopathic Urticaria with the presence of Helicobacter pylori infection-clinical and laboratory data correlation

Thumbnail

D2.22 - Evaluating the Role of Telemedicine in Allergy Care: Patient Preferences and Experiences

Thumbnail

D2.23 - The Natural Course Of Allergic Rhinitis In Cat Owners With Cat Allergy

Thumbnail

D2.24 - Vicilins – an overlooked group of storage protein allergens in walnut and hazelnut

Thumbnail

D2.25 - The spectrum of sensitization in atopic dermatitis in patients living in the Far East of Russia

Thumbnail

D2.26 - Analysis of Sensitization Profiles and Cross-Reactivity of Lipocalin Allergens in Czech Allergy Patients

Thumbnail

D2.27 - Interregional differences in molecular profiles of sensitization to respiratory allergens in the Russian population

Thumbnail

D2.28 - Interregional differences in the prevalence of sensitization to food allergens in different regions of Russia

Thumbnail

D2.29 - Assessing Individual Pollen Allergies Using Self-reported Real-World Allergy Burden Data

Thumbnail

D2.30 - Combined sensitization among patients with allergic rhinitis and bronchial asthma: changes during the war in Ukraine

Thumbnail

D2.31 - An Unexpected Easter Surprise: Anaphylaxis Triggered by Colored Candy Eggs

Thumbnail

D2.32 - Assessment of local nasal IgE in patients with suspected dual allergic rhinitis before and after nasal allergen provocation – presentation of 6 cases

Thumbnail

D2.351 - Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria

Thumbnail

D2.352 - Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria

Thumbnail

D2.353 - A Single Dose of Briquilimab, An Anti-Human CD117 (c-Kit) Antibody, Protects Against Relapse of Epicutaneous Allergen-Induced Dermatitis in Mice Expressing Chimeric Human/Mouse CD117

Thumbnail

D2.354 - Questionnaire survey of new treatments for atopic dermatitis

Thumbnail

D2.355 - Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria

Thumbnail

D2.356 - Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria